                         SEQUENCE LISTING

<110>  Yissum Research Development Company of the Hebrew 
       University of Jerusalem Ltd.
 
<120>  SELECTIVE DESTRUCTION OF CELLS

<130>  YISSUM-0119 PCT

<150>  USP 62/509,119
<151>  2017-05-21

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  1

Trp Thr Ala Val Gln Met Ala Val Phe Ile His Asn Phe Lys Arg Lys 
1               5                   10                  15      


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Trp Thr His Leu Glu Gly Lys Ile Ile Leu Val Ala Val His Val Ala 
1               5                   10                  15      


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Trp Gly Ser Asn Phe Thr Ser Thr Thr Val Lys Ala 
1               5                   10          


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Thr Ala Val Gln Met Ala Val Phe Ile His Asn Phe Lys Arg Lys 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  5

Thr His Leu Glu Gly Lys Ile Ile Leu Val Ala Val His Val Ala 
1               5                   10                  15  


<210>  6
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  6

Gly Ser Asn Phe Thr Ser Thr Thr Val Lys Ala 
1               5                   10      


<210>  7
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  7

Ala Gly Thr His His Trp Ile Leu Val Thr Glu Asn 
1               5                   10          


